518 related articles for article (PubMed ID: 9829713)
1. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
2. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
[TBL] [Abstract][Full Text] [Related]
5. Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women.
Davidson EJ; Davidson JA; Sterling JC; Baldwin PJ; Kitchener HC; Stern PL
Cancer Res; 2003 Jan; 63(2):400-3. PubMed ID: 12543794
[TBL] [Abstract][Full Text] [Related]
6. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
Sasagawa T; Basha W; Yamazaki H; Inoue M
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies.
Wang SS; Hildesheim A; Gao X; Schiffman M; Herrero R; Bratti MC; Sherman ME; Barnes WA; Greenberg MD; McGowan L; Mortel R; Schwartz PE; Zaino RJ; Glass AG; Burk RD; Karacki P; Carrington M
J Infect Dis; 2002 Sep; 186(5):598-605. PubMed ID: 12195346
[TBL] [Abstract][Full Text] [Related]
8. High-risk HPVs and risk of cervical neoplasia: a nested case-control study.
Coker AL; Gerasimova T; King MR; Jackson KL; Pirisi L
Exp Mol Pathol; 2001 Apr; 70(2):90-5. PubMed ID: 11263952
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
[TBL] [Abstract][Full Text] [Related]
10. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population.
Montoya L; Saiz I; Rey G; Vela F; Clerici-Larradet N
Eur J Immunogenet; 1998 Oct; 25(5):329-37. PubMed ID: 9805655
[TBL] [Abstract][Full Text] [Related]
11. HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students.
Mahmud SM; Robinson K; Richardson H; Tellier PP; Ferenczy AS; Roger M; Coutlee F; Franco EL
J Infect Dis; 2007 Jul; 196(1):82-90. PubMed ID: 17538887
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
[TBL] [Abstract][Full Text] [Related]
13. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
Apple RJ; Erlich HA; Klitz W; Manos MM; Becker TM; Wheeler CM
Nat Genet; 1994 Feb; 6(2):157-62. PubMed ID: 8162070
[TBL] [Abstract][Full Text] [Related]
14. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
15. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
Hildesheim A; Herrero R; Castle PE; Wacholder S; Bratti MC; Sherman ME; Lorincz AT; Burk RD; Morales J; Rodriguez AC; Helgesen K; Alfaro M; Hutchinson M; Balmaceda I; Greenberg M; Schiffman M
Br J Cancer; 2001 May; 84(9):1219-26. PubMed ID: 11336474
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection.
Maciag PC; Schlecht NF; Souza PS; Rohan TE; Franco EL; Villa LL
J Infect Dis; 2002 Jul; 186(2):164-72. PubMed ID: 12134251
[TBL] [Abstract][Full Text] [Related]
17. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated virus is associated with a lower risk of high-grade cervical neoplasia.
Coker AL; Russell RB; Bond SM; Pirisi L; Liu Y; Mane M; Kokorina N; Gerasimova T; Hermonat PL
Exp Mol Pathol; 2001 Apr; 70(2):83-9. PubMed ID: 11263951
[TBL] [Abstract][Full Text] [Related]
19. HPV-16 and HLA-DRB1 alleles are associated with cervical carcinoma in Mexican Mestizo women.
Alaez-Verson C; Berumen-Campos J; Munguía-Saldaña A; Flores-Aguilar H; Guardado-Estrada M; Rodríguez-Gomez A; Gorodezky-Lauferman C
Arch Med Res; 2011 Jul; 42(5):421-5. PubMed ID: 21911185
[TBL] [Abstract][Full Text] [Related]
20. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
